1. Black, B.L. and Olson, E.N. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol., 14: 167–196.
2. Centrella, M., Casinghino, S., Kim, J., Pham, T., Rosen, V., Wozney, J., and McCarthy, T.L. 1995. Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Mol. Cell. Biol., 15: 3273–3281.
3. Chen, D., Chen, H., Feng, J.Q., Windle, J.J., Koop, B.A., Harris, M.A., Bonewald, L.F., Boyce, B.F., Wozney, J.M., Mundy, G.R., and Harris, S.E. 1995. Osteoblast cell lines derived from a transgenic mouse containing the osteocalcin promoter driving SV40 T-antigen. Mol. Cell. Differ., 3: 193–212.
4. Dalei, S. and Lazar, M.A. 1997. Peroxisome proliferators activated receptor γ, CCAAT/enhancer-binding protein α, and cell cycle status regulate the commitment to adipocyte differentiation. J. Biol. Chem., 272: 21473–21478.
5. de Crombrugghe, B., Lefebvre, V., Behringer, R.R., Bi, W., Murakami, S., and Huang, W. 2000. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol., 19: 389–394.